Europe approves vaccine to protect newborns from RSV winter virus
The vaccine, Abrysvo, is the first RSV vaccine indicated for passive immunisation of babies from birth to six months old, after the mother is vaccinated during pregnancy.
A vaccine to protect newborn babies from the RSV winter virus has been approved for the first time in Europe and could soon be available in Ireland.
The vaccine, Abrysvo, is the first RSV vaccine indicated for passive immunisation of babies from birth to six months old, after the mother is vaccinated during pregnancy. This vaccine, developed by Pfizer, is also indicated for immunising adults aged 60 and older, the European Medicines Agency (EMA) said.
